RxDoctor Payments Data

Robert Mackie, MD

Family Medicine · Sault Sainte Marie, MINPI 1891797098

Payments from drug & device makers

$692in general payments, 2019–2025

Across 51 payments — averaging $13.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$157
  • Novo Nordisk$100
  • AstraZeneca$62
  • Johnson & Johnson$52
  • AbbVie$46
  • Amgen$44
  • plus $231 from 11 others

What the payments were for

  • Food & beverage$68098%
  • Education$122%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$692 in reported general payments places this provider in the 65th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$17,934
Medicare patients
68
Services billed
224

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban174$125,204
IngrezzaValbenazine Tosylate27$93,577
OzempicSemaglutide59$82,922
TrulicityDulaglutide78$81,172
FarxigaDapagliflozin Propanediol65$76,139
XareltoRivaroxaban60$67,460
JardianceEmpagliflozin65$61,309
JanuviaSitagliptin Phosphate37$55,470
RexultiBrexpiprazole49$36,364
Trelegy ElliptaFluticasone/Umeclidin/Vilanter43$29,828
Potassium Chloride138$12,959
EntrestoSacubitril/Valsartan11$9,760
Atorvastatin Calcium386$7,664
Losartan Potassium373$5,238
Omeprazole276$4,697

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$157$125,204174 claims
Novo NordiskOzempic$100$82,92259 claims
Lilly USA, LLCTrulicity$12$81,17278 claims
AstraZenecaFarxiga$62$76,13965 claims
Johnson & JohnsonXarelto$52$67,46060 claims
Boehringer IngelheimJardiance$17$61,30965 claims
MerckJanuvia$25$55,47037 claims
GSKTrelegy Ellipta$12$29,82843 claims
NovartisEntresto$27$9,76011 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 3,945 family medicine providers in Michigan.

Other family medicine in Sault Sainte Marie

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →